世界の泌尿器がん治療薬市場

QYResearchが発行した調査報告書(DATA909X17175)
◆英語タイトル:Global Urological Cancer Therapeutics Drugs Market Professional Survey Report 2019
◆商品コード:DATA909X17175
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月22日
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥577,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥770,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、泌尿器がん治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ゾーフィゴ(塩化ラジウム223)、ジェブタナ(カバジタキセル)、インライタ(アキシチニブ)、ヴォトリエント(パゾパニブ塩酸塩)、スーテント(スニチニブリンゴ酸塩)、ザイティガ(アビラテロン酢酸エステル)、イクスタンジ(エンザルタミド)、オプジーボ(ニボルマブ)、プロベンジ(シプリューセルT)に、用途別には、病院、医学研究所、その他にセグメント区分し、泌尿器がん治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・泌尿器がん治療薬の世界市場概要
・泌尿器がん治療薬の製造コスト構成分析
・泌尿器がん治療薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・泌尿器がん治療薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・泌尿器がん治療薬のセグメント分析(種類別)
(ゾーフィゴ(塩化ラジウム223)、ジェブタナ(カバジタキセル)、インライタ(アキシチニブ)、ヴォトリエント(パゾパニブ塩酸塩)、スーテント(スニチニブリンゴ酸塩)、ザイティガ(アビラテロン酢酸エステル)、イクスタンジ(エンザルタミド)、オプジーボ(ニボルマブ)、プロベンジ(シプリューセルT))
・泌尿器がん治療薬のセグメント分析(用途別)
(病院、医学研究所、その他)
・泌尿器がん治療薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Novartis、Pfizer、Johnson & Johnson、AstraZeneca、Astellas、Bristol-Myers Squibb、Abbott Laboratories、Celgene Corporation、Dendreon Corporation、Ferring Pharmaceuticals、GlaxoSmithKline plc、Indevus Pharmaceuticals Inc、Ipsen、Roche Healthcare、Sanofi S.A.、)
・泌尿器がん治療薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Urological Cancer Therapeutics Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Urological Cancer Therapeutics Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Urological Cancer Therapeutics Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Urological Cancer Therapeutics Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Urological Cancer Therapeutics Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline plc
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Xofigo (radium Ra 223 dichloride)
Jevtana (cabazitaxel)
Inlyta (axitinib)
Votrient (pazopanib hydrochloride)
Sutent (sunitinib malate)
Zytiga (abiraterone acetate)
Xtandi (enzalutamide)
Opdivo (nivolumab)
Provenge (sipuleucel-T)

Segment by Application
Hospital
Medical Research Laboratory
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Urological Cancer Therapeutics Drugs
1.1 Definition of Urological Cancer Therapeutics Drugs
1.2 Urological Cancer Therapeutics Drugs Segment by Type
1.2.1 Global Urological Cancer Therapeutics Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Xofigo (radium Ra 223 dichloride)
1.2.3 Jevtana (cabazitaxel)
1.2.4 Inlyta (axitinib)
1.2.5 Votrient (pazopanib hydrochloride)
1.2.6 Sutent (sunitinib malate)
1.2.7 Zytiga (abiraterone acetate)
1.2.8 Xtandi (enzalutamide)
1.2.9 Opdivo (nivolumab)
1.2.10 Provenge (sipuleucel-T)
1.3 Urological Cancer Therapeutics Drugs Segment by Applications
1.3.1 Global Urological Cancer Therapeutics Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Global Urological Cancer Therapeutics Drugs Overall Market
1.4.1 Global Urological Cancer Therapeutics Drugs Revenue (2014-2025)
1.4.2 Global Urological Cancer Therapeutics Drugs Production (2014-2025)
1.4.3 North America Urological Cancer Therapeutics Drugs Status and Prospect (2014-2025)
1.4.4 Europe Urological Cancer Therapeutics Drugs Status and Prospect (2014-2025)
1.4.5 China Urological Cancer Therapeutics Drugs Status and Prospect (2014-2025)
1.4.6 Japan Urological Cancer Therapeutics Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Urological Cancer Therapeutics Drugs Status and Prospect (2014-2025)
1.4.8 India Urological Cancer Therapeutics Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Urological Cancer Therapeutics Drugs
2.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
2.4 Industry Chain Structure of Urological Cancer Therapeutics Drugs

3 Development and Manufacturing Plants Analysis of Urological Cancer Therapeutics Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Urological Cancer Therapeutics Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Urological Cancer Therapeutics Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Urological Cancer Therapeutics Drugs Production and Capacity Analysis
4.2 Urological Cancer Therapeutics Drugs Revenue Analysis
4.3 Urological Cancer Therapeutics Drugs Price Analysis
4.4 Market Concentration Degree

5 Urological Cancer Therapeutics Drugs Regional Market Analysis
5.1 Urological Cancer Therapeutics Drugs Production by Regions
5.1.1 Global Urological Cancer Therapeutics Drugs Production by Regions
5.1.2 Global Urological Cancer Therapeutics Drugs Revenue by Regions
5.2 Urological Cancer Therapeutics Drugs Consumption by Regions
5.3 North America Urological Cancer Therapeutics Drugs Market Analysis
5.3.1 North America Urological Cancer Therapeutics Drugs Production
5.3.2 North America Urological Cancer Therapeutics Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Urological Cancer Therapeutics Drugs Import and Export
5.4 Europe Urological Cancer Therapeutics Drugs Market Analysis
5.4.1 Europe Urological Cancer Therapeutics Drugs Production
5.4.2 Europe Urological Cancer Therapeutics Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Urological Cancer Therapeutics Drugs Import and Export
5.5 China Urological Cancer Therapeutics Drugs Market Analysis
5.5.1 China Urological Cancer Therapeutics Drugs Production
5.5.2 China Urological Cancer Therapeutics Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Urological Cancer Therapeutics Drugs Import and Export
5.6 Japan Urological Cancer Therapeutics Drugs Market Analysis
5.6.1 Japan Urological Cancer Therapeutics Drugs Production
5.6.2 Japan Urological Cancer Therapeutics Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Urological Cancer Therapeutics Drugs Import and Export
5.7 Southeast Asia Urological Cancer Therapeutics Drugs Market Analysis
5.7.1 Southeast Asia Urological Cancer Therapeutics Drugs Production
5.7.2 Southeast Asia Urological Cancer Therapeutics Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Urological Cancer Therapeutics Drugs Import and Export
5.8 India Urological Cancer Therapeutics Drugs Market Analysis
5.8.1 India Urological Cancer Therapeutics Drugs Production
5.8.2 India Urological Cancer Therapeutics Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Urological Cancer Therapeutics Drugs Import and Export

6 Urological Cancer Therapeutics Drugs Segment Market Analysis (by Type)
6.1 Global Urological Cancer Therapeutics Drugs Production by Type
6.2 Global Urological Cancer Therapeutics Drugs Revenue by Type
6.3 Urological Cancer Therapeutics Drugs Price by Type

7 Urological Cancer Therapeutics Drugs Segment Market Analysis (by Application)
7.1 Global Urological Cancer Therapeutics Drugs Consumption by Application
7.2 Global Urological Cancer Therapeutics Drugs Consumption Market Share by Application (2014-2019)

8 Urological Cancer Therapeutics Drugs Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.3.2 Johnson & Johnson Product Introduction, Application and Specification
8.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 AstraZeneca
8.4.1 AstraZeneca Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.4.2 AstraZeneca Product Introduction, Application and Specification
8.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Astellas
8.5.1 Astellas Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.5.2 Astellas Product Introduction, Application and Specification
8.5.3 Astellas Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bristol-Myers Squibb
8.6.1 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.6.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Abbott Laboratories
8.7.1 Abbott Laboratories Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.7.2 Abbott Laboratories Product Introduction, Application and Specification
8.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Celgene Corporation
8.8.1 Celgene Corporation Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.8.2 Celgene Corporation Product Introduction, Application and Specification
8.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Dendreon Corporation
8.9.1 Dendreon Corporation Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.9.2 Dendreon Corporation Product Introduction, Application and Specification
8.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Ferring Pharmaceuticals
8.10.1 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Production Sites and Area Served
8.10.2 Ferring Pharmaceuticals Product Introduction, Application and Specification
8.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 GlaxoSmithKline plc
8.12 Indevus Pharmaceuticals Inc
8.13 Ipsen
8.14 Roche Healthcare
8.15 Sanofi S.A.

9 Development Trend of Analysis of Urological Cancer Therapeutics Drugs Market
9.1 Global Urological Cancer Therapeutics Drugs Market Trend Analysis
9.1.1 Global Urological Cancer Therapeutics Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Urological Cancer Therapeutics Drugs Regional Market Trend
9.2.1 North America Urological Cancer Therapeutics Drugs Forecast 2019-2025
9.2.2 Europe Urological Cancer Therapeutics Drugs Forecast 2019-2025
9.2.3 China Urological Cancer Therapeutics Drugs Forecast 2019-2025
9.2.4 Japan Urological Cancer Therapeutics Drugs Forecast 2019-2025
9.2.5 Southeast Asia Urological Cancer Therapeutics Drugs Forecast 2019-2025
9.2.6 India Urological Cancer Therapeutics Drugs Forecast 2019-2025
9.3 Urological Cancer Therapeutics Drugs Market Trend (Product Type)
9.4 Urological Cancer Therapeutics Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Urological Cancer Therapeutics Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Urological Cancer Therapeutics Drugs
Table Global Urological Cancer Therapeutics Drugs Production (Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Urological Cancer Therapeutics Drugs Production Market Share by Types in 2018
Figure Xofigo (radium Ra 223 dichloride) Product Picture
Figure Jevtana (cabazitaxel) Product Picture
Figure Inlyta (axitinib) Product Picture
Figure Votrient (pazopanib hydrochloride) Product Picture
Figure Sutent (sunitinib malate) Product Picture
Figure Zytiga (abiraterone acetate) Product Picture
Figure Xtandi (enzalutamide) Product Picture
Figure Opdivo (nivolumab) Product Picture
Figure Provenge (sipuleucel-T) Product Picture
Table Global Urological Cancer Therapeutics Drugs Consumption (Units) Comparison by Applications (2014-2025)
Figure Global Urological Cancer Therapeutics Drugs Consumption Market Share by Applications in 2018
Figure Hospital
Figure Medical Research Laboratory
Figure Others
Figure Global Urological Cancer Therapeutics Drugs Revenue (Million USD) (2014-2025)
Figure Global Urological Cancer Therapeutics Drugs Production (Units) (2014-2025)
Figure North America Urological Cancer Therapeutics Drugs Market Size (Million USD) (2014-2025)
Figure Europe Urological Cancer Therapeutics Drugs Market Size (Million USD) (2014-2025)
Figure China Urological Cancer Therapeutics Drugs Market Size (Million USD) (2014-2025)
Figure Japan Urological Cancer Therapeutics Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Market Size (Million USD) (2014-2025)
Figure India Urological Cancer Therapeutics Drugs Market Size (Million USD) (2014-2025)
Table Urological Cancer Therapeutics Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Urological Cancer Therapeutics Drugs in 2018
Figure Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
Figure Industry Chain Structure of Urological Cancer Therapeutics Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Urological Cancer Therapeutics Drugs Manufacturing Plants Distribution
Table Urological Cancer Therapeutics Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Urological Cancer Therapeutics Drugs Capacity (Units) of Major Manufacturers (2014-2019)
Table Urological Cancer Therapeutics Drugs Production (Units) of Major Manufacturers (2014-2019)
Table Urological Cancer Therapeutics Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Urological Cancer Therapeutics Drugs Production Share by Manufacturers in 2018
Table Urological Cancer Therapeutics Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Urological Cancer Therapeutics Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers in 2018
Table Urological Cancer Therapeutics Drugs Average Price (K USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Urological Cancer Therapeutics Drugs Production by Regions 2014-2019 (Units)
Table Global Urological Cancer Therapeutics Drugs Production Market Share by Regions 2014-2019
Figure Global Urological Cancer Therapeutics Drugs Production Market Share by Regions in 2018
Table Global Urological Cancer Therapeutics Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Urological Cancer Therapeutics Drugs Revenue Market Share by Regions 2014-2019
Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share by Regions in 2018
Table Global Urological Cancer Therapeutics Drugs Consumption by Regions 2014-2019 (Units)
Table Global Urological Cancer Therapeutics Drugs Consumption Market Share by Regions 2014-2019
Figure North America Urological Cancer Therapeutics Drugs Production Growth Rate 2014-2019 (Units)
Figure North America Urological Cancer Therapeutics Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Urological Cancer Therapeutics Drugs Production, Consumption Import and Export (Units)
Figure Europe Urological Cancer Therapeutics Drugs Production Growth Rate 2014-2019 (Units)
Figure Europe Urological Cancer Therapeutics Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Urological Cancer Therapeutics Drugs Production, Consumption Import and Export (Units)
Figure China Urological Cancer Therapeutics Drugs Production Growth Rate 2014-2019 (Units)
Figure China Urological Cancer Therapeutics Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Urological Cancer Therapeutics Drugs Production, Consumption Import and Export (Units)
Figure Japan Urological Cancer Therapeutics Drugs Production Growth Rate 2014-2019 (Units)
Figure Japan Urological Cancer Therapeutics Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Urological Cancer Therapeutics Drugs Production, Consumption Import and Export (Units)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Production Growth Rate 2014-2019 (Units)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Urological Cancer Therapeutics Drugs Production, Consumption Import and Export (Units)
Figure India Urological Cancer Therapeutics Drugs Production Growth Rate 2014-2019 (Units)
Figure India Urological Cancer Therapeutics Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Urological Cancer Therapeutics Drugs Production, Consumption Import and Export (Units)
Figure Global Consumption Urological Cancer Therapeutics Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Urological Cancer Therapeutics Drugs Market Share by Application (2014-2019)
Table Novartis Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Novartis Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table Novartis Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Novartis Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table Novartis Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure Novartis Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table Novartis Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table Pfizer Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Pfizer Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table Pfizer Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table Pfizer Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure Pfizer Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table Pfizer Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table AstraZeneca Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table AstraZeneca Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table AstraZeneca Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table AstraZeneca Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure AstraZeneca Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table AstraZeneca Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table Astellas Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Astellas Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table Astellas Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Astellas Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table Astellas Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure Astellas Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table Astellas Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table Celgene Corporation Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Celgene Corporation Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table Celgene Corporation Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Celgene Corporation Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table Celgene Corporation Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table Celgene Corporation Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product Introduction, Application and Specification
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Production Growth Rate (2014-2019)
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Production Market Share (2014-2019)
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Revenue Market Share (2014-2019)
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Main Business and Markets Served
Table GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Ipsen Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Roche Healthcare Urological Cancer Therapeutics Drugs Production Sites and Area Served
Table Sanofi S.A. Urological Cancer Therapeutics Drugs Production Sites and Area Served
Figure Global Urological Cancer Therapeutics Drugs Production (Units) Growth Rate Forecast 2019-2025
Figure Global Urological Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Forecast 2019-2025
Figure North America Urological Cancer Therapeutics Drugs Production Growth Rate Forecast 2019-2025 (Units)
Figure North America Urological Cancer Therapeutics Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Urological Cancer Therapeutics Drugs Production Growth Rate Forecast 2019-2025 (Units)
Figure Europe Urological Cancer Therapeutics Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Urological Cancer Therapeutics Drugs Production Growth Rate Forecast 2019-2025 (Units)
Figure China Urological Cancer Therapeutics Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Urological Cancer Therapeutics Drugs Production Growth Rate Forecast 2019-2025 (Units)
Figure Japan Urological Cancer Therapeutics Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Production Growth Rate Forecast 2019-2025 (Units)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Urological Cancer Therapeutics Drugs Production Growth Rate Forecast 2019-2025 (Units)
Figure India Urological Cancer Therapeutics Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (Units) of Urological Cancer Therapeutics Drugs by Type (2019-2025)
Table Global Consumption (Units) of Urological Cancer Therapeutics Drugs by Application (2019-2025)
Table Urological Cancer Therapeutics Drugs Distributors List
Table Urological Cancer Therapeutics Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Novartis、Pfizer、Johnson & Johnson、AstraZeneca、Astellas、Bristol-Myers Squibb、Abbott Laboratories、Celgene Corporation、Dendreon Corporation、Ferring Pharmaceuticals、GlaxoSmithKline plc、Indevus Pharmaceuticals Inc、Ipsen、Roche Healthcare、Sanofi S.A.、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の泌尿器がん治療薬市場(Global Urological Cancer Therapeutics Drugs Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。